These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 3615935)

  • 1. [Development of dialysis encephalopathy in the context of rubidium and aluminum levels in the blood and cerebral cortex of patients with concomitant uremic polyneuropathy on long-term dialysis].
    Adamiec R; Uzar J
    Przegl Lek; 1987; 44(3):309-14. PubMed ID: 3615935
    [No Abstract]   [Full Text] [Related]  

  • 2. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity.
    Scholtz CL; Swash M; Gray A; Kogeorgos J; Marsh F
    Clin Neuropathol; 1987; 6(3):93-7. PubMed ID: 3608291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].
    Cartier F; Allain P; Gary J; Chatel M; Menault F; Pecker S
    Nouv Presse Med; 1978 Jan; 7(2):97-102. PubMed ID: 652514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity.
    Bugiani O; Brancaccio D; Ghetti B
    Clin Nephrol; 1985; 24 Suppl 1():S20-5. PubMed ID: 3915956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubidium deficiency in dialysis patients.
    Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Pietra R; Fortaner S; Jacono F; Angelini G; Gallieni M; Fop F; Sabbioni E
    J Nephrol; 2001; 14(3):169-75. PubMed ID: 11439740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dialysis encephalopathy.
    Alfrey AC
    Clin Nephrol; 1985; 24 Suppl 1():S15-9. PubMed ID: 3915955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 12. [The importance of aluminiun in dialyseencephalopathie (author's transl)].
    Ladurner G; Holzer H; Wawschinek O; Pogglitsch H; Petek W
    Fortschr Neurol Psychiatr; 1981 May; 49(5):211-3. PubMed ID: 7239409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Uremic polyneuropathy in patients treated by chronic hemodialysis].
    Il'ina NA; Ermolenko VM; Ostroumova IV; Ivanchenko OV; Potomskaia LZ
    Sov Med; 1974 Nov; (11):93-8. PubMed ID: 4373841
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive dialysis encephalopathy from dialysate aluminum.
    Rozas VV; Port FK; Rutt WM
    Arch Intern Med; 1978 Sep; 138(9):1375-7. PubMed ID: 686928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodialysis therapy of uremic encephalopathy in acute renal insufficiency].
    Bogolepov NK; Aristova RA
    Klin Med (Mosk); 1970 Feb; 48(2):61-7. PubMed ID: 5425985
    [No Abstract]   [Full Text] [Related]  

  • 16. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 17. Dialysis encephalopathy in Kuala Lumpur.
    Abu Bakar Suleiman ; Rejab SM; Khoo HE
    Med J Malaysia; 1986 Mar; 41(1):12-8. PubMed ID: 3796341
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain gamma-aminobutyric acid deficiency in dialysis encephalopathy.
    Sweeney VP; Perry TL; Price JD; Reeve CE; Godolphin WJ; Kish SJ
    Neurology; 1985 Feb; 35(2):180-4. PubMed ID: 3969205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle molecular weight substances in the cerebrospinal fluid of uremic patients.
    Sperschneider H; Spustova V; Stein G; Dzurik R
    Clin Nephrol; 1982 Jun; 17(6):298-302. PubMed ID: 7105504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis encephalopathy associated with polyvalent ion contamination.
    Hocken AG
    N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.